Related Experiment Video
Updated: Feb 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Evaluation of the TRPM2 channel as a biomarker in breast cancer using public databases analysis
Adriana Sumoza-Toledo1, Mario Iván Espinoza-Gabriel2, Dvorak Montiel-Condado3
1Instituto de Investigaciones Médico-Biológicas, Universidad Veracruzana, Veracruz, Veracruz, Mexico.
Background:
Breast cancer is one of the most common malignancies affecting women. Recent investigations have revealed a major role of ion channels in cancer. The transient receptor potential melastatin-2 (TRPM2) is a plasma membrane and lysosomal channel with important roles in cell migration and cell death in immune cells and tumor cells.
Methods:
In this study, we investigated the prognostic value of TRPM2 channel in breast cancer, analyzing public databases compiled in Oncomine™ (Thermo Fisher, Ann Arbor, MI) and online Kaplan-Meier Plotter platforms.
Results:
The results revealed that TRPM2 mRNA overexpression is significant in situ and invasive breast carcinoma compared to normal breast tissue. Furthermore, multi-gene validation using Oncomine™ showed that this channel is coexpressed with proteins related to cellular migration, transformation, and apoptosis. On the other hand, Kaplan-Meier analysis exhibited that low expression of TRPM2 could be used to predict poor outcome in ER- and HER2+ breast carcinoma patients.
Conclusions:
TRPM2 is a promising biomarker for aggressiveness of breast cancer, and a potential target for the development of new therapies.
Insights
Transient Receptor Potential Melastatin-2 (TRPM2) channel is overexpressed in breast cancer. Low TRPM2 expression predicts poor outcomes in certain breast cancer subtypes, suggesting its role as a prognostic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biophysics
Background:
- Breast cancer is a prevalent malignancy in women.
- Ion channels play a significant role in cancer progression.
- Transient Receptor Potential Melastatin-2 (TRPM2) is implicated in cell migration and death.
Purpose of the Study:
- To investigate the prognostic value of TRPM2 in breast cancer.
- To analyze TRPM2 expression patterns in breast carcinoma.
- To evaluate TRPM2 as a potential biomarker for breast cancer aggressiveness.
Main Methods:
- Analysis of public databases: Oncomine™ and Kaplan-Meier Plotter.
- Investigated TRPM2 mRNA expression levels in breast cancer tissues.
- Correlated TRPM2 expression with patient outcomes and coexpressed genes.
Main Results:
- TRPM2 mRNA is significantly overexpressed in invasive and in situ breast carcinoma compared to normal tissue.
- TRPM2 coexpression with genes involved in cellular migration, transformation, and apoptosis.
- Low TRPM2 expression is associated with poor prognosis in ER- and HER2+ breast cancer patients.
Conclusions:
- TRPM2 serves as a promising biomarker for breast cancer aggressiveness.
- TRPM2 represents a potential therapeutic target for novel breast cancer treatments.
Related Concept Videos
Cancer Survival Analysis
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Levels of Communication II: Organizational, Public, and Group Dynamics
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Channels of Non-Verbal Communication

